MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Transcranial Magnetic Stimulation in Parkinsonism. Tremor and Biomechanics Evaluation

    D. Labunskiy, S. Kiryukhina, A. Hamed, N. Dzhalolitdinova, S. Abdulsahib (Saransk, Russian Federation)

    Objective: The aim of our study was to reveal the relationship between motor and muscle activity шт terms of plantar pressure distribution PPD) in Parkinson's…
  • MDS Virtual Congress 2021

    Challenges in Implementing Relevant Exercise Interventions in Mouse Models of Parkinson’s Disease

    D. Grogan, H. Skelton, J. Rubiano, C. Gutekunst, R. Gross (Augusta, USA)

    Objective: To determine the suitability of a motorized wheel as a forced exercise modality that does not rely on aversive stimuli for use in Parkinson’s…
  • MDS Virtual Congress 2021

    Emotional processing and response times in Parkinson’s disease

    A. Botta, G. Lagravinese, E. Pelosin, G. Bonassi, M. Putzolu, C. Cosentino, C. Ponte, S. Mezzarobba, L. Avanzino (Genova, Italy)

    Objective: The aim of this behavioural study was to test whether motor response is mainly driven by the emotional content of a picture or if…
  • MDS Virtual Congress 2021

    Dissociable contribution of serum NfL and p-tau181 to cognitive impairment and mild cognitive impairment in Parkinson’s disease.

    J. Pagonabarraga, R. Pérez-González, H. Bejr-Kasem, A. Horta-Barba, I. Aracil-Bolaños, S. Martinez-Horta, E. Rivas-Asensio, J. Perez-Perez, F. Sampedro, A. Campolongo, C. Izquierdo, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To analyze the contribution of serum NfL and p-tau181 levels to cognitive impairment and mild cognitive impairment (PD-MCI) in non-demented PD patients. Background: Autopsy…
  • MDS Virtual Congress 2021

    The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

    G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, G. Tayupova, S. Umutbaev, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)

    Objective: The aim of our study is to search for genetic risk factors for the development of motor side effects of dopaminergic therapy, such as…
  • MDS Virtual Congress 2021

    Building a Global Parkinson’s Genetics Program (GP2): Clinical Cohorts Integration Working Group

    J. Joubert, M. Tan, T. Antar, A. Martinez-Carrasco, H. Iwaki, H. Morris, GP2. Genetics Program (London, United Kingdom)

    Objective: To recruit Parkinson's Disease (PD) cohorts across the world for the global Parkinson's Genetics Program (GP2, http://gp2.org/), harmonise clinical data across cohorts for joint…
  • MDS Virtual Congress 2021

    Stratified genome-wide association study revealed novel interactions for the top hit Parkinson’s disease loci.

    K. Senkevich, S. Bandres-Ciga, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)

    Objective: To identify genetic modifiers and interactors that may modulate known risk variants in the SNCA, TMEM175 and MAPT loci in Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

    M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)

    Objective: To identify protein biomarkers in plasma of patients with Parkinson’s disease (PD). Background: Inflammation plays a key role in the initiation and progression of…
  • MDS Virtual Congress 2021

    PD phenotype with premotor RBD is associated with a dysbiotic profile of gut microbiota.

    V. Oppo, S. Vascellari, M. Melis, A. Manzin, G. Cossu (Cagliari, Italy)

    Objective: The aim of the study was to compare the fecal microbial composition of a group of PD patients with and without premotor RBD. Background:…
  • MDS Virtual Congress 2021

    Cerebral white matter atrophy may be associated with the performance of activities of daily livings in patients with Parkinson’s disease

    YK. Chen, ZH. Lu, XL. Fu (Dongguan, China)

    Objective: To assess whether global or regional brain structural abnormalities are associated performance of activities of daily livings (ADL) in patients with Parkinson's disease (PD).…
  • « Previous Page
  • 1
  • …
  • 419
  • 420
  • 421
  • 422
  • 423
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley